IPO Trending
AVIENCESME / NSELive

Avience Biomedicals Limited

Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, and export of molecular diagnostic solutions for the biotechnology, genomics, and in-vitro diagnostics (IVD) sectors. The company offers a wide range of healthcare products, including rapid test kits, molecular diagnostic kits, biochemistry and hematology analyzers, medical devices, and diagnostic reagents. Its products serve pathology laboratories, hospitals, microbiology labs, and research centers in India and overseas. Along with manufacturing, the company also operates as a distributor and trader of medical equipment. Its manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, Avience Biomedicals had 75 permanent employees and 33 contractual employees.

₹196 - ₹208GMP ₹7245.42x sub
GMP+₹72
Est. Listing Price₹280
Subscription45.42x total demandUpdated 21 Jun 2026, 12:07 PM
QIB0.03x
Steady / DevelopingOffered: 2,73,600 sh
Nib67.11x
🔥 Blockbuster Sizzling Demand!Offered: 2,07,000 sh
Hnis(10l +)66.67x
🔥 Blockbuster Sizzling Demand!Offered: 1,38,000 sh
Hnis (2-10l)67.98x
🔥 Blockbuster Sizzling Demand!Offered: 69,000 sh
Retail61.90x
🔥 Blockbuster Sizzling Demand!Offered: 4,81,200 sh
CategoryOfferedAppliedTimes
QIB2,73,6007,8000.03x
Nib2,07,0001,38,91,80067.11x
Hnis(10l +)1,38,00092,01,00066.67x
Hnis (2-10l)69,00046,90,80067.98x
Retail4,81,2002,97,85,20061.9x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB0.165.690.03x
Fis0.040Open
Others0.120Open
Retail619.5310.0161.89x
Nib288.954.3167.04x
Hnis 2+97.571.4467.76x
Hnis 10+191.382.8766.68x
Application-wise Breakup
CategoryReservedAppliedTimes Sub.
QIB04Open
Nib03,880Open
Retail40124,82161.90x
Hnis(10l +)771,60820.88x
Hnis (2-10l)382,32061.05x